Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Harrow (HROW) EBITDA: 2013-2025

Historic EBITDA for Harrow (HROW) over the last 13 years, with Sep 2025 value amounting to $14.7 million.

  • Harrow's EBITDA rose 1016.35% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year increase of 410.80%. This contributed to the annual value of $8.8 million for FY2024, which is 1946.87% up from last year.
  • Harrow's EBITDA amounted to $14.7 million in Q3 2025, which was up 29.26% from $11.4 million recorded in Q2 2025.
  • Harrow's EBITDA's 5-year high stood at $14.7 million during Q3 2025, with a 5-year trough of -$11.2 million in Q1 2025.
  • For the 3-year period, Harrow's EBITDA averaged around $2.2 million, with its median value being $1.5 million (2024).
  • As far as peak fluctuations go, Harrow's EBITDA surged by 1,955.32% in 2023, and later slumped by 672.56% in 2024.
  • Quarterly analysis of 5 years shows Harrow's EBITDA stood at -$1.8 million in 2021, then fell by 1.31% to -$1.8 million in 2022, then plummeted by 174.18% to -$4.9 million in 2023, then spiked by 364.59% to $12.9 million in 2024, then spiked by 1,016.35% to $14.7 million in 2025.
  • Its EBITDA stands at $14.7 million for Q3 2025, versus $11.4 million for Q2 2025 and -$11.2 million for Q1 2025.